Yankaskas Bonnie C, Gill Karminder S
Department of Radiology, University of North Carolina, Chapel Hill, 27599, USA.
Cancer. 2005 Dec 15;104(12):2671-81. doi: 10.1002/cncr.21550.
A previous study compared the performance (sensitivity, specificity, positive predictive value, and cancer detection rate) of screening mammography in Black and White women. No study, to the authors' knowledge, has evaluated the difference in the performance of diagnostic mammography between Black and White women.
Univariate analysis was used to evaluate differences in characteristics and cancers between Black and White women. Stratified and adjusted logistic regression analyses were used to test the association of Black and White race with performance measures of diagnostic mammography.
The sensitivity of diagnostic mammography was higher (91% vs. 84%) and specificity was lower (86% vs. 90%) among Black women compared with White women. After controlling for age, density, self-reported breast problems, and previous mammography, sensitivity was significantly higher (odds ratio [OR] = 1.82, 95% confidence interval [CI] = 1.22-2.80) and specificity was significantly lower (OR = 0.75, 95% CI = 0.70-0.81) among Black women. The crude cancer detection rate of mammography was higher for Black women (42.6/1000) than for White women (31.0/1000) and Black women had a higher proportion of cancers that were > 2.0 cm (57.4% vs. 46.2%) that were more often poorly differentiated (61.7% vs. 49.3%) and were more often estrogen-receptor and progesterone-receptor negative.
Black women have lower specificity of diagnostic mammography and, consequently, more unnecessary workups than White women. Black women have higher sensitivity of diagnostic mammography, with cancers that are larger and more advanced than White women. Delay in responding to signs and symptoms would explain the size and later stage. However, more research is needed to understand the biologic differences of breast cancer characteristics between Black and White women.
此前有一项研究比较了黑人女性和白人女性筛查性乳腺钼靶检查的性能(敏感性、特异性、阳性预测值和癌症检出率)。据作者所知,尚无研究评估黑人女性和白人女性诊断性乳腺钼靶检查性能的差异。
采用单因素分析评估黑人女性和白人女性在特征及癌症方面的差异。使用分层和调整后的逻辑回归分析来检验黑人和白人种族与诊断性乳腺钼靶检查性能指标之间的关联。
与白人女性相比,黑人女性诊断性乳腺钼靶检查的敏感性更高(91% 对 84%),而特异性更低(86% 对 90%)。在控制年龄、密度、自我报告的乳腺问题和既往乳腺钼靶检查情况后,黑人女性的敏感性显著更高(优势比 [OR] = 1.82,95% 置信区间 [CI] = 1.22 - 2.80),而特异性显著更低(OR = 0.75,95% CI = 0.70 - 0.81)。黑人女性乳腺钼靶检查的粗癌症检出率高于白人女性(42.6/1000 对 31.0/1000),且黑人女性癌症尺寸 > 2.0 cm 的比例更高(57.4% 对 46.2%),这些癌症分化程度更低的情况更常见(61.7% 对 49.3%),且雌激素受体和孕激素受体阴性的情况更常见。
黑人女性诊断性乳腺钼靶检查的特异性较低,因此与白人女性相比,会有更多不必要的检查。黑人女性诊断性乳腺钼靶检查的敏感性更高,其患的癌症比白人女性更大且更晚期。对体征和症状反应延迟可以解释癌症的大小和较晚分期。然而,需要更多研究来了解黑人女性和白人女性乳腺癌特征的生物学差异。